"The TAME Cardiac Arrest Trial is a 1700 patient pragmatic, parallel group, randomised controlled trial evaluating the effect of mild hypercarbia in resuscitated patients post cardiac arrest. This ANZICS Clinical Trials Group investigation is presently recruiting centres and patients - if you would like to take part, please contact Dr Glenn Eastwood at the below email address."
Further Details:
- Targeted therapeutic mild hypercapnia after cardiac arrest: A phase II multi-centre randomised controlled trial (the CCC trial). (abstract)
- ANZICS Clinical Trials Group
- Glenn Eastwood on Twitter
- email: glenn.eastwood@austin.org.au